LLY News

Recent headlines mentioning LLY, newest first.

LLY bearish

PJP vs. IYH: Which Healthcare ETF Is the Better Buy?

finance.yahoo.com·Jul 20, 2026·The iShares U.S. Healthcare ETF (NYSEMKT:IYH) provides broad exposure to the medical sector at a lower cost, while the Invesco Pharmaceuticals ETF (NYSEMKT:PJP)...
LLY neutral

IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?

finance.yahoo.com·Jul 19, 2026·Investors comparing the iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) and the iShares Global Healthcare ETF (NYSEMKT:IXJ) must choose between concentrated U.S....
LLY neutral

Atlas Healthcare Fund by VST Capital Entered Eli Lilly at $350 in 2020 - The Stock Now Trades Above $1,200

manilatimes.net·Jul 17, 2026·NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Atlas Healthcare Fund managed by VST Capital , today highlighted a series of early conviction investment decisions t...
LLY neutral

AdvanCell Closes $315 Million Series D

vcnewsdaily.com·Jul 16, 2026·AdvanCell Closes $315 Million Series D Back to Home BOSTON, MA, AdvanCell, a clinical-stage radiopharmaceutical company, announced the closing of an oversubscr...
LLY neutral

Tuberculosis Clinical Trial Pipeline Shows Potential with Active Contributions from 28+ Key Companies | DelveInsight

manilatimes.net·Jul 14, 2026·The tuberculosis clinical trial analysis report delivers important insights into ongoing research of 30+ pipeline tuberculosis drugs, clinical strategies, upcom...
LLY bullish

Wall Street Lifts Obesity Drug Targets for Eli Lilly and AbbVie as Medicare Coverage Expands

investorideas.com·Jul 10, 2026·Biotech · Markets Commentary NYSE: LLY JPMorgan lifted Eli Lilly to $1,400 and AbbVie drew a string of target hikes as a new Medicare GLP-1 program widens acc...
LLY neutral

Flare Therapeutics Secures $85M Series C Round

vcnewsdaily.com·Jul 10, 2026·Flare Therapeutics Secures $85M Series C Round Back to Home CAMBRIDGE, MA, Flare Therapeutics, a clinical-stage biotechnology company, announced the closing of...
LLY neutral

Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%

finance.yahoo.com·Jul 9, 2026·Quick Read OZEM holds Lilly at 16% and Novo Nordisk at 13%, concentrating nearly 30% in GLP-1 leaders versus XLV's diluted multi-sector exposure. OZEM rounds ...
LLY bearish

Inside THNR: A Leaner Approach to Weight Loss Investing

etftrends.com·Jul 7, 2026·Demand for GLP-1 weight loss drugs has reshaped the healthcare industry. And ETFs such as the Amplify Weight Loss Drug & Treatment ETF (THNR) give investors a w...
LLY bearish

CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?

finance.yahoo.com·Jul 7, 2026·Viking Therapeutics is a clinical-stage biopharmaceutical company that develops therapies for metabolic and endocrine disorders. Its primary focus is on obesity...
LLY bullish

Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

finance.yahoo.com·Jul 6, 2026·Can high-flying growth justify a premium valuation, or is a recovered value play the safer bet for 2026? Investors are weighing Eli Lilly and (NYSE:LLY) against...
LLY bullish

Eli Lilly and Company (LLY) Fell on Regulatory And Pricing Policy Challenges

insidermonkey.com·Jul 6, 2026·When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward...
LLY neutral

Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know

zacks.com·Jul 6, 2026·We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
LLY neutral

Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years?

finance.yahoo.com·Jul 6, 2026·The short, but glib, answer to the headline question posed for Viking Therapeutics (NASDAQ: VKTX) investors is "no," because the likelihood is that the $4.6 bil...
LLY bearish

IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?

finance.yahoo.com·Jul 5, 2026·The iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) offers lower fees and a higher dividend yield, while the Invesco Pharmaceuticals ETF (NYSEMKT:PJP) spreads it...
LLY bullish

Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly

finance.yahoo.com·Jul 4, 2026·Quick Read Mounjaro and Zepbound drove Lilly's revenue up 56% while JNJ grew 10% and extended its dividend streak to 64 consecutive years. Lilly partnered wit...
LLY neutral

Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China

manilatimes.net·Jun 30, 2026·SAN FRANCISCO and SUZHOU, China, June 30, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
LLY neutral

Eli Lilly and Company (LLY) Up More Than 6% Over the Past Month, Can it Move Higher?

finance.yahoo.com·Jun 29, 2026·Eli Lilly and Company (NYSE:LLY) is one of the Stocks That Will Make You Rich Over the Next 3 Years. Eli Lilly and Company (NYSE:LLY) has gained roughly 6% over...
LLY bullish

Eli Lilly and Company (LLY) Up More Than 6% Over the Past Month, Can it Move Higher?

insidermonkey.com·Jun 29, 2026·When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward...
LLY neutral

Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology

manilatimes.net·Jun 29, 2026·CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , June 29, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical c...
LLY neutral

Is Eli Lilly and Company (LLY) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds?

finance.yahoo.com·Jun 28, 2026·Eli Lilly and Company (NYSE:LLY) is among the Best Healthcare Stocks Stocks.On June 23, Reuters reported that Eli Lilly and Company (NYSE:LLY) expects to launch...
LLY neutral

Lilly launches cancer therapy drug Tanstrive

thehindubusinessline.com·Jun 25, 2026·Eli Lilly and Company India Pvt Ltd has launched Tanstrive (selpercatinib) in India, for patients with locally advanced or metastatic solid tumors with a rearra...
LLY neutral

Tanstrive cost, dosage: Eli Lilly launches cancer drug in India, priced at ₹2.15 lakh per box

livemint.com·Jun 25, 2026·Eli Lilly and Company India on Thursday announced the launch of its cancer treatment drug Tanstrive in India. The launch follows marketing authorisation from t...
LLY neutral

ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement

manilatimes.net·Jun 25, 2026·LEIDEN, Netherlands and CAMBRIDGE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) ("ProQR”), a clinical-stage biotechnology c...
LLY bullish

Eli Lilly and Company (LLY) – Among the 10 Reliable Dividend Stocks to Buy for Long-Term Investors

insidermonkey.com·Jun 25, 2026·When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward...
LLY neutral

Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas

manilatimes.net·Jun 23, 2026·Sangamo intends to complete asset sale transactions through a voluntary Chapter 11 reorganization, in an effort to maximize business value for all stakeholders ...
LLY bullish

Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales

manilatimes.net·Jun 22, 2026·BOSTON and LONDON, June 22, 2026 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines f...
LLY neutral

Sitryx Completes Enrollment in Phase 1b Trial of First-in-Class Oral PKM2 Modulator SYX-5219 in Atopic Dermatitis

manilatimes.net·Jun 22, 2026·Phase 1b clinical trial of SYX-5219 in adults with moderate to severe atopic dermatitis completes enrollment ahead of schedule Rapid progress in the United Sta...
LLY neutral

Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma

manilatimes.net·Jun 22, 2026·SAN FRANCISCO and SUZHOU, China, June 22, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
LLY bullish

Eli Lilly and Company (LLY) is one of the Best Growth Stocks to Buy According Ray Dalio

insidermonkey.com·Jun 18, 2026·When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward...
LLY bullish

What’s Happening at Eli Lilly and Company (LLY)’s Pipeline? Early Signals Emerge

insidermonkey.com·Jun 18, 2026·When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard. Fast forward...
LLY neutral

Jim Cramer on Eli Lilly: “I Want You to Stay in the Stock”

finance.yahoo.com·Jun 17, 2026·Eli Lilly and Company (NYSE:LLY) was among Jim Cramer’s stock calls on Mad Money, as he highlighted worthy space players and reviewed several of this year’s...
LLY bullish

10 Best Growth Stocks to Buy According to Billionaire Ray Dalio’s Bridgewater Associates

finance.yahoo.com·Jun 17, 2026·Agnico Eagle Mines Limited (NYSE:AEM) is one of the best growth stocks to buy, according to billionaire Ray Dalio’s Bridgewater Associates. On June 4, Agnico ...
LLY bullish

Glioblastoma Clinical Trial Landscape Expands: Over 200 Companies Advancing Next-Generation Therapies | DelveInsight

manilatimes.net·Jun 16, 2026·The glioblastoma clinical trial analysis report delivers important insights into ongoing research of 220+ pipeline glioblastoma drugs, clinical strategies, upco...
LLY bullish

Frost & Sullivan Institute Celebrates Visionary Companies Addressing the World's Most Pressing Challenges

manilatimes.net·Jun 15, 2026·SILICON VALLEY, Calif., June 16, 2026 /PRNewswire/ -- The Frost & Sullivan Institute is pleased to present the 2026 Visionary Growth Leadership Best Practices R...
LLY bullish

Is Eli Lilly (LLY) One Of The Most Profitable Blue Chip Stocks To Buy According To Hedge Funds?

finance.yahoo.com·Jun 13, 2026·With a profit margin of 34.99% and net income of $20.64 billion (FY25), Eli Lilly and Company (NYSE:LLY) ranks among the most profitable blue chip stocks to buy...
LLY bullish

Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriers

economictimes.indiatimes.com·Jun 13, 2026·Live Events ET Bureau Dementia affects an estimated 8.8 m people in country as a Reliable and Trusted News Source Addas a Reliable and Trusted News Source A...
LLY neutral

Jim Cramer Wasn’t Selling Eli Lilly (LLY)

finance.yahoo.com·Jun 13, 2026·We recently published Jim Cramer Didn’t Hold Back On SpaceX’s IPO & Discussed These 12 Stocks. Eli Lilly and Company (NYSE:LLY) is one of the stocks discus...
LLY neutral

Eli Lilly (LLY) Moves to Enforce 340B Claims Data Reporting Compliance

finance.yahoo.com·Jun 12, 2026·Eli Lilly and Company (NYSE:LLY) is one of the 7 Best Compounder Stocks to Buy Now. Eli Lilly and Company (NYSE:LLY) plans to stop providing 340B discounted d...
LLY bullish

Weekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data

rttnews.com·Jun 12, 2026·This week, the biotech sector saw a surge of FDA, EU, and China approvals spanning oncology, dermatology, autoimmune and rare disease indications. Strategic acq...